Published in Med J Aust on November 07, 2005
Effects of Laugh Therapy Associated to Cardiopulmonary Rehab | NCT02824120
Development and feasibility of a smartphone, ECG and GPS based system for remotely monitoring exercise in cardiac rehabilitation. PLoS One (2011) 1.48
Health related quality of life trajectories and predictors following coronary artery bypass surgery. Health Qual Life Outcomes (2006) 1.01
Are the processes recommended by the NHMRC for improving Cardiac Rehabilitation (CR) for Aboriginal and Torres Strait Islander people being implemented?: an assessment of CR Services across Western Australia. Aust New Zealand Health Policy (2009) 0.89
Improving cardiac rehabilitation attendance and completion through quality improvement activities and a motivational program. J Cardiopulm Rehabil Prev (2013) 0.84
The effect of cardiac rehabilitation on quality of life in patients with acute coronary syndrome. Iran J Nurs Midwifery Res (2015) 0.82
Automatic assessment of socioeconomic impact on cardiac rehabilitation. Int J Environ Res Public Health (2013) 0.80
Estimating the payoffs from cardiovascular disease research in Canada: an economic analysis. CMAJ Open (2013) 0.78
The clinical consequences of a pre-hospital diagnosis of stroke by the emergency medical service system. A pilot study. Scand J Trauma Resusc Emerg Med (2012) 0.78
The Contribution of Individual Exercise Training Components to Clinical Outcomes in Randomised Controlled Trials of Cardiac Rehabilitation: A Systematic Review and Meta-regression. Sports Med Open (2017) 0.75
Tai Chi Chuan for cardiac rehabilitation in patients with coronary arterial disease. Arq Bras Cardiol (2014) 0.75
Internet-based training of coronary artery patients: the Heart Cycle Trial. Heart Vessels (2016) 0.75
Allocation concealment and blinding: when ignorance is bliss. Med J Aust (2005) 2.85
Determining the sample size in a clinical trial. Med J Aust (2002) 2.51
Interventions for prevention of post-operative atrial fibrillation and its complications after cardiac surgery: a meta-analysis. Eur Heart J (2006) 2.12
Inclusion of patients in clinical trial analysis: the intention-to-treat principle. Med J Aust (2003) 2.06
Effect of fenofibrate on amputation events in people with type 2 diabetes mellitus (FIELD study): a prespecified analysis of a randomised controlled trial. Lancet (2009) 1.88
Lipid-modifying therapies and risk of pancreatitis: a meta-analysis. JAMA (2012) 1.71
Stroke risk and antithrombotic strategies in atrial fibrillation. Stroke (2010) 1.62
Supraventricular tachycardia. Med J Aust (2009) 1.54
Statistical methods in clinical trials. Med J Aust (2003) 1.47
Subgroup analysis in clinical trials. Med J Aust (2004) 1.42
Putting results of a clinical trial into perspective. Med J Aust (2007) 1.42
Randomisation in clinical trials. Med J Aust (2002) 1.40
iPhone ECG application for community screening to detect silent atrial fibrillation: a novel technology to prevent stroke. Int J Cardiol (2013) 1.30
Long-term effects of fenofibrate on carotid intima-media thickness and augmentation index in subjects with type 2 diabetes mellitus. J Am Coll Cardiol (2008) 1.26
Specifying objectives and outcomes for clinical trials. Med J Aust (2002) 1.24
Assessment of voluntary pelvic floor muscle contraction in continent and incontinent women using transperineal ultrasound, manual muscle testing and vaginal squeeze pressure measurements. Int Urogynecol J Pelvic Floor Dysfunct (2006) 1.24
Can self-rated health scores be used for risk prediction in patients with type 2 diabetes? Diabetes Care (2008) 1.18
Incidence and predictors of silent myocardial infarction in type 2 diabetes and the effect of fenofibrate: an analysis from the Fenofibrate Intervention and Event Lowering in Diabetes (FIELD) study. Eur Heart J (2009) 1.17
Using the EQ-5D index score as a predictor of outcomes in patients with type 2 diabetes. Med Care (2009) 1.12
Therapeutic effects of PPARα agonists on diabetic retinopathy in type 1 diabetes models. Diabetes (2012) 1.08
Benefits and safety of long-term fenofibrate therapy in people with type 2 diabetes and renal impairment: the FIELD Study. Diabetes Care (2011) 1.08
Comparison of transperineal and transabdominal ultrasound in the assessment of voluntary pelvic floor muscle contractions and functional manoeuvres in continent and incontinent women. Int Urogynecol J Pelvic Floor Dysfunct (2006) 1.07
Effects of a water-based program on women 65 years and over: a randomised controlled trial. Aust J Physiother (2005) 1.05
Antithrombotic therapy in patients treated with oral anticoagulation undergoing coronary artery stenting. An expert consensus document with focus on atrial fibrillation. Ann Med (2008) 1.03
Impact of metabolic syndrome and its components on cardiovascular disease event rates in 4900 patients with type 2 diabetes assigned to placebo in the FIELD randomised trial. Cardiovasc Diabetol (2011) 1.02
Acute coronary syndromes: consensus recommendations for translating knowledge into action. Med J Aust (2009) 1.02
A randomised controlled trial of a self-management education program for osteoarthritis of the knee delivered by health care professionals. Arthritis Res Ther (2012) 1.01
The angiographic and clinical benefits of mibefradil in the coronary slow flow phenomenon. J Am Coll Cardiol (2004) 0.98
Development and testing of innovative patient resources for the management of coronary heart disease (CHD): a descriptive study. BMC Health Serv Res (2006) 0.96
Physical activity levels of adolescents with congenital heart disease. Aust J Physiother (2003) 0.95
Glycemic control over 5 years in 4,900 people with type 2 diabetes: real-world diabetes therapy in a clinical trial cohort. Diabetes Care (2012) 0.95
Geometric indices of bone strength are associated with physical activity and dietary calcium intake in healthy older women. J Bone Miner Res (2007) 0.95
Baseline data in clinical trials. Med J Aust (2003) 0.95
Associations between turnout and lower extremity injuries in classical ballet dancers. J Orthop Sports Phys Ther (2005) 0.94
Differences in muscle activation patterns during pelvic floor muscle contraction and Valsalva maneuver. Neurourol Urodyn (2006) 0.93
Do sleep problems or urinary incontinence predict falls in elderly women? Aust J Physiother (2006) 0.90
An update on the molecular actions of fenofibrate and its clinical effects on diabetic retinopathy and other microvascular end points in patients with diabetes. Diabetes (2013) 0.90
Effect of pravastatin compared with placebo initiated within 24 hours of onset of acute myocardial infarction or unstable angina: the Pravastatin in Acute Coronary Treatment (PACT) trial. Am Heart J (2004) 0.89
Changes in lipoprotein-Associated phospholipase A2 activity predict coronary events and partly account for the treatment effect of pravastatin: results from the Long-Term Intervention with Pravastatin in Ischemic Disease study. J Am Heart Assoc (2013) 0.89
Rates and predictors of risk of stroke and its subtypes in diabetes: a prospective observational study. J Neurol Neurosurg Psychiatry (2012) 0.89
Lifestyle influences on 9-year changes in BMD in young women. J Bone Miner Res (2004) 0.89
Multiple analyses in clinical trials: sound science or data dredging? Med J Aust (2004) 0.89
The effects of manual pelvic compression on trunk motor control during an active straight leg raise in chronic pelvic girdle pain subjects. Man Ther (2009) 0.88
Relationships of HDL cholesterol, ApoA-I, and ApoA-II with homocysteine and creatinine in patients with type 2 diabetes treated with fenofibrate. Arterioscler Thromb Vasc Biol (2009) 0.87
Patient-centered modular secondary prevention following acute coronary syndrome: a randomized controlled trial. J Cardiopulm Rehabil Prev (2008) 0.86
Generalising the results of trials to clinical practice. Med J Aust (2004) 0.86
Altered muscle activation patterns in symptomatic women during pelvic floor muscle contraction and Valsalva manouevre. Neurourol Urodyn (2006) 0.85
Long-term fenofibrate therapy increases fibroblast growth factor 21 and retinol-binding protein 4 in subjects with type 2 diabetes. J Clin Endocrinol Metab (2012) 0.85
The relationship of fibroblast growth factor 21 with cardiovascular outcome events in the Fenofibrate Intervention and Event Lowering in Diabetes study. Diabetologia (2014) 0.83
Effects of fenofibrate on cardiovascular events in patients with diabetes, with and without prior cardiovascular disease: The Fenofibrate Intervention and Event Lowering in Diabetes (FIELD) study. Am Heart J (2012) 0.82
Balloon warming time is the strongest predictor of late pulmonary vein electrical reconnection following cryoballoon ablation for atrial fibrillation. Heart Rhythm (2013) 0.82
Shoulder strength and range of motion in female amateur-league tennis players. J Orthop Sports Phys Ther (2004) 0.82
Motor control patterns during an active straight leg raise in chronic pelvic girdle pain subjects. Spine (Phila Pa 1976) (2009) 0.80
Atrial fibrillation. Med J Aust (2007) 0.80
The effectiveness of pulsed electrical stimulation (E-PES) in the management of osteoarthritis of the knee: a protocol for a randomised controlled trial. BMC Musculoskelet Disord (2008) 0.80
An old friend in a new light: the role of osteocalcin in energy metabolism. Cardiovasc Ther (2011) 0.79
An evidence based clinical aid for cardiovascular disease--what do GPs think? Aust Fam Physician (2005) 0.79
Motor control patterns during an active straight leg raise in pain-free subjects. Spine (Phila Pa 1976) (2009) 0.79
Plasma homocysteine and the risk of venous thromboembolism: insights from the FIELD study. Clin Chem Lab Med (2012) 0.79
Influence of history of heart failure on diagnostic performance and utility of B-type natriuretic peptide testing for acute dyspnea in the emergency department. Am Heart J (2006) 0.78
Cholesterol-lowering therapy with pravastatin in patients with average cholesterol levels and established ischaemic heart disease: is it cost-effective? Med J Aust (2002) 0.78
Pre-treatment with the synthetic antioxidant T-butyl bisphenol protects cerebral tissues from experimental ischemia reperfusion injury. J Neurochem (2014) 0.78
Favourable effects of fenofibrate on lipids and cardiovascular disease in women with type 2 diabetes: results from the Fenofibrate Intervention and Event Lowering in Diabetes (FIELD) study. Diabetologia (2014) 0.78
Subgroup analysis: application to individual patient decisions. Med J Aust (2004) 0.77
Is home warfarin self-management effective? Results of the randomised Self-Management of Anticoagulation Research Trial. Int J Cardiol (2013) 0.77
Recruitment to randomised studies. Med J Aust (2003) 0.77
Beta-blocker dose up-titration or addition of ivabradine in stable angina: more is not necessarily better : editorial to: "efficacy of ivabradine in combination with beta-blocker versus uptitration of beta-blocker in patients with stable angina" by E. Amosova et al. Cardiovasc Drugs Ther (2011) 0.77
Assessment of osteoporotic fracture risk in community settings: a study of post-menopausal women in Australia. Health Soc Care Community (2008) 0.76
The effect of increased physical load during an active straight leg raise in pain free subjects. J Electromyogr Kinesiol (2010) 0.76
Self-management for osteoarthritis of the knee: does mode of delivery influence outcome? BMC Musculoskelet Disord (2010) 0.76
Effectiveness of pulsed electrical stimulation in the management of osteoarthritis of the knee: three case reports. Physiother Theory Pract (2009) 0.76
Reply: the latest generation of troponin immunoassays: the "cholesterol" of the third millennium? J Am Coll Cardiol (2014) 0.75
Forming networks for research: proposal for an Australian clinical trials alliance. Med J Aust (2013) 0.75
What do we know about perioperative ischaemic cardiac events in patients undergoing non-cardiac surgery? Med J Aust (2006) 0.75
Specifying interventions in a clinical trial. Med J Aust (2002) 0.75
Relationship of fibroblast growth factor 21 with baseline and new on-study microvascular disease in the Fenofibrate Intervention and Event Lowering in Diabetes study. Diabetologia (2015) 0.75
The role of statin therapy in patients with lower vascular risk. Med J Aust (2012) 0.75
Secondary and tertiary prevention in the management of low-trauma fracture. Aust J Physiother (2003) 0.75
Erratum to: Favourable effects of fenofibrate on lipids and cardiovascular disease in women with type 2 diabetes: results from the Fenofibrate Intervention and Event Lowering in Diabetes (FIELD) study. Diabetologia (2015) 0.75
Clinical utility of calcaneal quantitative ultrasonometry and thoracic kyphosis assessments in identifying vertebral fractures in community settings. J Rheumatol (2008) 0.75
Baseline Circulating FGF21 Concentrations and Increase after Fenofibrate Treatment Predict More Rapid Glycemic Progression in Type 2 Diabetes: Results from the FIELD Study. Clin Chem (2017) 0.75
Clinical trials research in the new millennium: the International Clinical Trials Symposium, Sydney, 21-23 October 2002. Med J Aust (2003) 0.75
The effect of resisted inspiration during an active straight leg raise in pain-free subjects. J Electromyogr Kinesiol (2009) 0.75
Micronized fenofibrate: a useful choice for the correction of dyslipidemia in metabolic syndrome and Type 2 diabetes. Future Cardiol (2006) 0.75
Making sense of trial results: outcomes and estimation. Med J Aust (2004) 0.75
Flow of participants in randomised studies. Med J Aust (2003) 0.75